References: 1. Kumar M, Ray K, Harode S, Wagh D .The pattern of benign breast diseases in rural hospital in India. East Cent Afr J Surg. 2010; 15(2): 59-64. 2. Darbre PD. Environmental estrogens, cosmetics and breast cancer. Best Pract Res Clin Endocrinol Metab. 2006; 20: 121-43. 3. Coriaty Nelson Z, Ray RM, Gao DL. Risk factors for fibroadenoma in a cohort of female textile workers in Shanghai, China. Am J Epidemiol. 2002; 156(7):599-605. 4. Santen RJ, Mansel R. Benign breast disorders. N Eng J Med. 2005; 21;353(3):275-85. 5. Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015;33(10):1128-35. 6. Santen RJ. Benign Breast Disease in Women. Deutsch Arztebl Int. 2019; 116(33):565. 7. Ajmal M, Van Fossen K. Breast Fibroadenoma. StatPearls. Treasure Island FL. StatPearls Publishing LLC; 2020. https://www.ncbi.nlm.nih. gov/books /NBK535345/ 8.Sagar A, Iyengar S, Sikarwar S, Mangal KS. Clinical and Histocytological Correlation of Breast Lesions. IOSR-J Dent Med Sci. 2020;19(5):12-6. 9. Abhijit MG, Anantharaman D, Bhoopal S, Ramanujam R. Benign breast diseases: experience at a teaching hospital in rural India. IJRMS. 2013;1(2):73-8. 10.Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer 2012;118(11):2796-803 11.Moore T, Lee AH. Expression of CD34 and bcl‐2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast. Histopathol. 2001; 38(1):62-7. 12. Li P, Xiao-Yin T, Cui D, Chi JC, Wang Z, et al. Evaluation of the safety and efficacy of percutaneous radiofrequency ablation for treating multiple breast fibroadenoma. J Cancer Res Ther. 2016; 12:138-42. 13. Panda SK, Patro B, Mishra J, Dora RK, Subudhi BS. Multiple fibroadenomas in bilateral breasts of a 46-year-old Indian woman: A case report. Int J Surg Case Rep 2014;5(5):262-4. 14. Rao S, Latha PS, Ravi A, Thanka J. Ductal carcinoma in a multiple fibroadenoma: diagnostic inaccuracies. J Cancer Res Ther. 2010;6(3):385-7 15. Haaghensen CD. Adenofibroma. In: W.B. Saunders Company (eds). Disease of the Breast. W.B. Saunders Company: Philadelphia, London, Toronto, Mexico City, Rio de Janeiro, Sydney, Tokyo, Honk Kong. Mod Pathol. 2006; 19: 599–606. 16. Carter B. A, Page D L, Schuyler P, Parl FF, Simpson JF, et al. No elevation in long‐term breast carcinoma risk for women with fibro adenomas that contain atypical hyperplasia. Cancer. 2001; 92(1): 30-36. 17. Desai M. Role of obstetrician and gynecologist in the management of breast lump. J obstet Gynecol India. 2003; 53:389-91. 18.Houssami N, Cheung MN, Dixon JM. Fibroadenoma of the breast. Med J Aust. 2001;174(4):185-8. 19.Vera-Sempere FJ, Artes Martínez J. Estrogen receptors and breast fibroadenoma with suspicious traits of malignancy. An Med Interna.1997; 14; 332-6. 20.Sapino A, Bosco M, Cassoni P. Estrogen receptorbeta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol.2006; 19:599-606. 21. Arbabi Bidgoli S, Ahmadi R, Zavarhei MD. Role of hormonal and environmental factors on early incidence of breast cancer in Iran. Sci Total Environ.2010; 408: 4056-61. 22.Lisiane Lopes da C, Milene Cristine P, Mariana de Moura ED, Renata Nascimento de F, Jose do Carmo Lopes M, Maria do Carmo Gouveia P. Benign Breast Disease and Associated Factors in Women Attending in A Public Hospital. Int J New Technol Res. 2016;6:14-8. 23.El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer. Breast. 2003, 12:302–307. 24. Muhammad Aslam H, Saleem SH, Arshad Shaikh H, Shahid N, Mughal A, Umah R. Clinico- pathological profile of patients with breast diseases. Diagn Pathol. 2013;8(77): 2-6. 25. Sezgin G, Coskun M, Apaydin M, Keceli M, Cetinoglu K, Tavusbay C. Interacting Factors of Strain Ratio Values in Fibroadenomas and the Contribution of Color Scale. J Med Ultrasound. 2020; 28(3):169-72. 26. Ali EA, Talaat S. Ultrasound Lexicon in diagnosis and management of breast fibroadenoma: when to follow up and when to biopsy. Egypt J Radiol Nucl. 2020; 51(17): 2-16 27. Lazarus SN, Gouse DHM, Kante DR. A Clinicopathological study of breast lesions in a Tribal population in rural Telangana: A 3-year retrospective analysis. Trop J Pathol Microbiol. 2021;7(5):232-6. 28.Gonenc A, Erten D, Aslan S, Akinci M, Simsek B, Torun M. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. J Int Cell Biol. 2006;30:376- 80. 29.Prabakar MS, Prakasam N, Reshma S, Loganathan K, Palani V. A clinical study of serum lipid profile in benign breast disease in a tertiary care hospital. Int Surg J. 2019; 6 (316): 2-4. 30. Khanna AK, Tapadar JK, Khanna HD, Khanna S, Khanna A. Behavior of estrogen receptor, histological correlation and clinical outcome in patients with benign breast disorder. Eur J Surg. 2002; 168:631-4. 31. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, et al. Association of serum adiponectin levels with breast cancer risk. Clin Canser Res. 2003; 9:5699–704. 32. Zeinomar N, Phillips KA, Daly MB, Milne RL, Dite GS, MacInnis RJ, et al. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort. Int J Cancer. 2019; 15;145(2):370-9. 33.Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs T, Peiro G, et al. Family history of breast cancer, age and benign breast disease. Int J cancer. 2002; 20;100(3):375-8. 34. Bhettani M.K, Mubarik R, Altaf H N, Ahmed Syed M , Tahir AA , Khan M.S , et al. Correlation Between Body Mass Index and Fibroadenoma. Cureus. 2019; 11(7): 5219. 35. Stacey O, Kowdley, Chandru G. Benign Breast Diseases and Body Mass Index: Is There a Correlation? Am Surg. 2014; 80(5):461-65. 36. Bidgoli SA, Eftekhari T. Role of exogenous and endogenous sources of estrogen on the incidence of breast fibroadenoma: case-control study in Iran. Asian Pac J Cancer Prev. 2011;12(5):1289-93. 37. Masoudifard M, Dehghani M, Darooghe L, Riahi H, Lame E. Investigating the factors influencing breast lumps in women referring to health centers in Aran and Bidgol. J Ilam Uni Med Sci. 2017; 25 (1) :103-09 38. Vessey M, Yeates D. Oral contraceptives and benign breast disease: an update of findings in a large cohort study. Contraception. 2007; 76(6):418-24
مجله علوم پزشکی پارس